Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis
Abstract Bacterial vaginosis (BV) is the most commonly diagnosed vaginal infection in women of reproductive age, with most patients unaware that they have BV due to its asymptomatic nature. BV is a dysbiotic condition defined by a deviation from the healthy Lactobacillus dominance to a polymicrobial...
Saved in:
| Main Authors: | Emmanuel Amabebe, Madhuri Tatiparthy, Ananth K. Kammala, Lauren S. Richardson, Brandie D. Taylor, Surendra Sharma, Ramkumar Menon |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | npj Biofilms and Microbiomes |
| Online Access: | https://doi.org/10.1038/s41522-025-00748-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exofection by exosomes: A transient functional cargo transfer
by: Ramkumar Menon, et al.
Published: (2025-06-01) -
Exosomal delivery of IL-10: Biodistribution, pharmacokinetics, and preterm birth prevention strategies
by: Brinley Harrington, et al.
Published: (2025-06-01) -
The Human Vaginal Bacterial Biota and Bacterial Vaginosis
by: Sujatha Srinivasan, et al.
Published: (2008-01-01) -
Extracellular Traps in Patients Diagnosed With Bacterial Vaginosis, Trichomoniasis, Candidiasis, Noninfectious Vaginitis and Cytolytic Vaginosis
by: María G. Ramírez-Ledesma, et al.
Published: (2024-01-01) -
Efficacy of dequalinium chloride vaginal tablets in treatment of bacterial vaginosis
by: A. B. Khuraseva, et al.
Published: (2018-11-01)